Cargando…

Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis

OBJECTIVE: To investigate the impact of dose reduction of tumor necrosis factor inhibitor (TNFi) on radiographic progression in ankylosing spondylitis (AS). METHODS: One hundred and sixty-five patients treated with etanercept or adalimumab were selected from a consecutive single-center observational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jun Won, Kwon, Hyun Mi, Park, Jin Kyun, Choi, Ja-Young, Lee, Eun Bong, Song, Yeong Wook, Lee, Eun Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199008/ https://www.ncbi.nlm.nih.gov/pubmed/28033420 http://dx.doi.org/10.1371/journal.pone.0168958

Ejemplares similares

Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment
por: Park, Jun Won, et al.
Publicado: (2018)

Predictive factors of radiographic progression in ankylosing spondylitis
por: Kim, Hyungjin, et al.
Publicado: (2015)

Baseline extent of damage predicts spinal radiographic progression in Korean patients with ankylosing spondylitis treated with golimumab
por: Lee, Jeong Seok, et al.
Publicado: (2018)

The Effects of Sex and Estrogen on Radiographic Progression of Ankylosing Spondylitis in Korean Patients
por: Jeong, Hyemin, et al.
Publicado: (2021)

Tumour necrosis factor inhibitor tapering in patients with ankylosing spondylitis at low disease activity: factors associated with flare
por: Kwon, Oh Chan, et al.
Publicado: (2021)

Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
por: Lee, Jeong-Won, et al.
Publicado: (2015)

Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
por: Jeong, Hyemin, et al.
Publicado: (2018)

Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
por: Kang, Ji-Hyoun, et al.
Publicado: (2014)

Pregnancy outcomes in Korean women with ankylosing spondylitis
por: Park, Eun Hye, et al.
Publicado: (2021)

Characteristics of hip involvement in patients with ankylosing spondylitis in Korea
por: Jeong, Hyemin, et al.
Publicado: (2017)

Cost-of-Illness and Quality of Life in Patients with Ankylosing Spondylitis at a Tertiary Hospital in Korea
por: Lee, Tae-Jin, et al.
Publicado: (2014)

Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis
por: Koo, Bon San, et al.
Publicado: (2021)

Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis
por: Nam, Bora, et al.
Publicado: (2023)

Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis
por: Kim, Tae-Hwan, et al.
Publicado: (2023)

Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: A preliminary 2-year longitudinal study
por: Park, Ji-Heh, et al.
Publicado: (2017)

Phenotype Difference between Familial and Sporadic Ankylosing Spondylitis in Korean Patients
por: Kim, Hye Won, et al.
Publicado: (2014)

The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment
por: Nam, Bora, et al.
Publicado: (2022)

Comorbidity, disability, and healthcare expenditure of ankylosing spondylitis in Korea: A population-based study
por: Lee, Jeong Seok, et al.
Publicado: (2018)

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
por: Ramiro, Sofia, et al.
Publicado: (2013)

Bone Morphogenetic Protein 6 Polymorphisms Are Associated with Radiographic Progression in Ankylosing Spondylitis
por: Joo, Young Bin, et al.
Publicado: (2014)

Clinical and Radiographic Features of Adult-onset Ankylosing Spondylitis in Korean Patients: Comparisons between Males and Females
por: Jung, Young-Ok, et al.
Publicado: (2010)

Prediction of radiographic progression pattern in patients with ankylosing spondylitis using group-based trajectory modeling and decision trees
por: Kang, Juyeon, et al.
Publicado: (2022)

The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
por: Lee, Suhwan, et al.
Publicado: (2019)

Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study
por: Park, Jun Won, et al.
Publicado: (2019)

Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor Agents
por: Lee, Jung-Sun, et al.
Publicado: (2020)

Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis
por: Seol, Jung Eun, et al.
Publicado: (2016)

Comparison of Outcomes of Total Hip Arthroplasty between Patients with Ankylosing Spondylitis and Avascular Necrosis of the Femoral Head
por: Lee, Sun-Ho, et al.
Publicado: (2017)

Bath Ankylosing Spondylitis Disease Activity Index is Associated With the Quality of Sleep in Ankylosing Spondylitis Patients
por: Song, Byung Wook, et al.
Publicado: (2021)

Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
por: Kim, Joon Wan, et al.
Publicado: (2013)

Bone and Cartilage Turnover Markers, Bone Mineral Density, and Radiographic Damage in Men with Ankylosing Spondylitis
por: Park, Min-Chan, et al.
Publicado: (2008)

The Epidemiology and Treatment of Ankylosing Spondylitis in Korea
por: Kwon, Seong-Ryul, et al.
Publicado: (2022)

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Giovanni, Orsolini, et al.
Publicado: (2018)

High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis
por: Moon, Dong-Hyuk, et al.
Publicado: (2023)

Gastrointestinal risk factors and patient‐reported outcomes of ankylosing spondylitis in Korea
por: Lee, Sang‐Hoon, et al.
Publicado: (2019)

Surgical Treatment of Lumbar Hyperextension Injury in Ankylosing Spondylitis
por: Lee, Jung Keun, et al.
Publicado: (2013)

Anti-tumor necrosis factor alpha treatment does not influence serum levels of the markers associated with radiographic progression in ankylosing spondylitis
por: Özdemirel, Ali Erhan, et al.
Publicado: (2023)

Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis
por: Hwang, Mark C., et al.
Publicado: (2021)

Impact of Infliximab Biosimilar CT-P13 Dose and Infusion Interval on Real-World Drug Survival and Effectiveness in Patients with Ankylosing Spondylitis
por: Lee, Shin-Seok, et al.
Publicado: (2021)

Tai Chi for Disease Activity and Flexibility in Patients with Ankylosing Spondylitis—A Controlled Clinical Trial
por: Lee, Eun-Nam, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ic645lotafhq1fmfcu73alq035